|
WO2013070988A2
|
|
Method of treating osteosarcoma
|
|
CN103561745A
|
|
Medicaments and methods for treating cancer
|
|
WO2012075210A2
|
|
Method for treating refractory cancer
|
|
WO2012075211A2
|
|
Combination therapy with a gallium complex
|
|
CA2818163A1
|
|
Method of treating hematological cancers
|
|
KR20140009212A
|
|
Method of treating neuroendocrine tumors
|
|
WO2012012304A2
|
|
Method of treating refractory cancer
|
|
WO2011139868A2
|
|
Method for treating esophageal cancer
|
|
WO2011139867A2
|
|
Method of treating brain cancer
|
|
CN102946878A
|
|
Method of treating prostate cancer
|
|
CA2831206A1
|
|
Method for treating pancreatic cancer
|
|
EP2560638A2
|
|
Method of treating gastric cancer
|
|
WO2011133479A2
|
|
Combination therapy with a proteasome inhibitor and a gallium complex
|
|
CN103108636A
|
|
Method for treating brain cancer
|
|
CN103002895A
|
|
Method for treating hematological cancers
|
|
KR20120104594A
|
|
Method of treating pancreatic cancer
|
|
WO2010121245A1
|
|
Method of treating hepatocellular carcinoma
|
|
NZ595482A
|
|
Method of treating osteoporosis
|
|
CN101677572A
|
|
Method of manufacturing a ruthenium complex
|
